Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 9, 1999Circulation

Intravenous Immunoglobulin Reduces Anti-HLA Alloreactivity and Shortens Waiting Time to Cardiac Transplantation in Highly Sensitized Left Ventricular Assist Device Recipients

View Full Paper
Ask AI
Bookmark
Share

Authors

RJRanjit JohnHeart Failure / CardiomyopathyKLK. LietzSentara Heart HospitalEBElizabeth BurkeCedars-Sinai Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

John et al. (1999) studied this question.

synapsesocial.com/papers/6a8ceb3cbccdcede27ff17dbhttps://doi.org/10.1161/01.cir.100.suppl_2.ii-229
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig.1989 · 253 citations
  2. 2SUPPRESSION OF HLA-SPECIFIC ALLOANTIBODIES BY HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIg)1993 · 169 citations
  3. 3Acute Renal Failure following Immunoglobulin Therapy1996 · 54 citations
  4. 4New York University/Hospital for Joint Diseases experience with intravenous cyclophosphamide treatment: efficacy in steroid unresponsive lupus nephritis1995 · 58 citations
  5. 5Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells.1987 · 106 citations